ANEB Latest Press Releases

-- February 12, 2026 --

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates Business Wire 4:15 PM

-- February 6, 2026 --

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC Business Wire 9:00 AM

-- January 29, 2026 --

Anebulo Pharmaceuticals Announces Final Results of Tender Offer Business Wire 9:00 AM

-- January 27, 2026 --

Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer Business Wire 9:00 AM

-- November 13, 2025 --

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates Business Wire 4:05 PM

-- September 29, 2025 --

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates Business Wire 4:05 PM

-- September 25, 2025 --

Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity Business Wire 7:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software